香农芯创(300475) - 2023 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2023 was ¥1,567,916,740.17, a decrease of 58.34% compared to ¥3,763,171,822.19 in the same period last year[7] - Net profit attributable to shareholders was ¥85,417,370.94, an increase of 55.54% from ¥54,917,501.44 year-on-year[7] - Total operating revenue for the current period is 1,567,916,740.17 CNY, compared to 3,763,171,822.19 CNY in the previous period, representing a decrease of approximately 58.3%[24] - Net profit for the current period is 86,714,970.62 CNY, an increase from 54,683,357.13 CNY in the previous period, reflecting a growth of about 58.5%[25] - The company’s total operating costs decreased to 1,522,809,948.09 CNY from 3,685,058,223.92 CNY, a reduction of about 58.7%[24] - Other comprehensive income after tax for the current period is -16,813,291.88 CNY, compared to -3,752,434.67 CNY in the previous period, indicating a decline in comprehensive income[25] Assets and Liabilities - Total assets at the end of the reporting period reached ¥4,734,094,188.41, an increase of 11.07% from ¥4,262,130,489.32 at the end of the previous year[7] - The company reported a total liability of ¥2,349,485,555.84, slightly up from ¥2,321,438,113.78, indicating a growth of approximately 1.2%[27] - Total assets increased to ¥4,734,094,188.41 from ¥4,262,130,489.32, representing a growth of approximately 11%[27] - The total number of shares held by the top ten shareholders represents a significant portion of the company's equity[15] Shareholder Information - The total number of common shareholders at the end of the reporting period is 8,439[15] - The largest shareholder, Shenzhen Lingxin Jishi Equity Investment Fund Management Partnership, holds 11.94% of shares, totaling 54,643,674 shares[15] - The second-largest shareholder holds 9.52% of shares, totaling 43,552,963 shares, with 39,593,603 shares pledged[15] - The company raised a total of 423.09 million RMB through a rights issue, with 37,565,767 shares subscribed, amounting to 378,287,273.69 RMB[19] - Following the rights issue, the total share capital increased from 420,000,000 shares to 457,565,767 shares[20] - The number of restricted shares at the beginning of the period was 15,750,000, with 1,575,000 shares added to the restricted category, resulting in a total of 17,325,000 restricted shares[18] - The company has a significant number of pledged shares, including 39,593,603 shares from the second-largest shareholder[15] - The company’s total equity rose to ¥457,565,767.00 from ¥420,000,000.00, an increase of approximately 9%[27] Cash Flow - The net cash flow from operating activities was -¥161,115,351.48, a significant decline of 1,587.35% compared to ¥10,832,356.66 in the previous year[7] - Cash and cash equivalents at the end of the period totaled ¥320,877,649.14, down from ¥506,625,053.41, a decrease of about 37%[47] - The net cash flow from investing activities was negative at -¥36,484,835.39, compared to a positive ¥16,291,659.92 in the previous period[34] Equity and Capital Structure - The company's equity attributable to shareholders increased by 23.09% to ¥2,357,378,432.73 from ¥1,915,173,033.16[7] - The company's capital reserve increased to ¥549,906,985.87 from ¥213,871,432.36, a substantial increase of about 157%[27] - The company has received regulatory approval for its rights issue, enhancing its capital structure[20] Operational Focus - The company is focused on meeting operational capital needs to support sustainable business development[19] - Research and development expenses for the current period are 2,056,709.99 CNY, slightly down from 2,224,545.74 CNY in the previous period, a decrease of approximately 7.5%[25] - The company reported a significant increase in cash and cash equivalents, with a balance of 322,697,509.61 CNY compared to 144,159,699.96 CNY at the beginning of the year, representing a growth of about 124.0%[26]